Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma

Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma

Linwei Fan,* Li Li,* Chunye Huang, Shanshan Huang, Jun Deng, Jianping Xiong Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun Deng; Ji...

Full description

Bibliographic Details
Main Authors: Fan L, Li L, Huang C, Huang S, Deng J, Xiong J
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:OncoTargets and Therapy
Subjects:
snx20
pd-l1
immunotherapy
tumor microenvironment
lung adenocarcinoma
Online Access:https://www.dovepress.com/increased-snx20-and-pd-l1-levels-can-predict-the-clinical-response-to--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/increased-snx20-and-pd-l1-levels-can-predict-the-clinical-response-to--peer-reviewed-article-OTT

Similar Items